LIP SCC

Clinical trials for LIP SCC explained in plain language.

Never miss a new study

Get alerted when new LIP SCC trials appear

Sign up with your email to follow new studies for LIP SCC, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Completed 1

New drug duo tested for Tough-to-Treat head and neck cancers

Disease control Completed

This study tested whether combining two existing cancer drugs, pembrolizumab and cetuximab, could help control advanced head and neck cancer that had returned or spread. It involved 78 patients at four US cancer centers, grouped based on their prior treatments. The main goal was …

Matched conditions: LIP SCC

Phase: PHASE2 • Sponsor: University of California, San Diego • Aim: Disease control

Last updated Mar 25, 2026 14:08 UTC

LIP SCC

Get alerted when new LIP SCC trials appear

New drug duo tested for Tough-to-Treat head and neck cancers